Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: Results from the Malaysia-Singapore ALL Study Group

Leukemia Research

Volumn 34, Issue 3, 2010, Pages 276-283

  Yeoh, Allen Eng Juh ^a   Lu, Yi ^a   Chan, Jason Yong Sheng ^a   Chan, Yiong Huak ^a   Ariffin, Hany ^b   Kham, Shirley Kow Yin ^a   Quah, Thuan Chong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Childhood ALL; Folate metabolism; Gender effect; Genetic epidemiology; Malay; NQO1; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; MULTIDRUG RESISTANCE PROTEIN 1; REDUCED FOLATE CARRIER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ETHNICITY; FEMALE; FOLATE METABOLISM; GENE DELETION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; PRIORITY JOURNAL; SINGAPORE;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALAYSIA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SEX CHARACTERISTICS; SINGAPORE; YOUNG ADULT;

EID: 77649179382     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.07.003     Document Type: Article

References (49)

1. Sinnett D., Krajinovic M., Labuda D. Genetic susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma 2000, 38(5-6):447-462.
2. Gast A., Bermejo J.L., Flohr T., Stanulla M., Burwinkel B., Schrappe M., et al. Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia 2007, 21(2):320-325.
3. Kim Y.I. Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis. Nutr Rev 2000, 58(7):205-209.
4. Thompson J.R., Gerald P.F., Willoughby M.L., Armstrong B.K. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 2001, 358(9297):1935-1940.
5. Smith G., Stanley L.A., Sim E., Strange R.C., Wolf C.R. Metabolic polymorphisms and cancer susceptibility. Cancer Surv 1995, 25:27-65.
6. Sinnett D., Labuda D., Krajinovic M. Challenges identifying genetic determinants of pediatric cancers-the childhood leukemia experience. Fam Cancer 2006, 5(1):35-47.
7. Ross D., Kepa J.K., Winski S.L., Beall H.D., Anwar A., Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact 2000, 129(1-2):77-97.
8. Strange R.C., Spiteri M.A., Ramachandran S., Fryer A.A. Glutathione-S-transferase family of enzymes. Mutat Res 2001, 482(1-2):21-26.
9. Jamroziak K., Robak T. Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies. Hematology 2004, 9(2):91-105.
10. Whetstine J.R., Gifford A.J., Witt T., Liu X.Y., Flatley R.M., Norris M., et al. Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers. Clin Cancer Res 2001, 7(11):3416-3422.
11. de Jonge R., Tissing W.J., Hooijberg J.H., Jansen G., Kaspers G.J., Lindemans J., et al. Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood 2009, 113(10):2284-2289.
12. Kim Y.I. Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr Rev 1999, 57(10):314-321.
13. Petra B.G., Janez J., Vita D. Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk Lymphoma 2007, 48(4):786-792.
14. Robien K., Ulrich C.M. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 2003, 157(7):571-582.
15. Papoutsakis C., Yiannakouris N., Manios Y., Papaconstantinou E., Magkos F., Schulpis K.H., et al. The effect of MTHFR(C677T) genotype on plasma homocysteine concentrations in healthy children is influenced by gender. Eur J Clin Nutr 2006, 60(2):155-162.
16. Franco R.F., Simoes B.P., Tone L.G., Gabellini S.M., Zago M.A., Falcao R.P. The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol 2001, 115(3):616-618.
17. Jamroziak K., Mlynarski W., Balcerczak E., Mistygacz M., Trelinska J., Mirowski M., et al. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol 2004, 72(5):314-321.
18. Kracht T., Schrappe M., Strehl S., Reiter A., Elsner H.A., Trka J., et al. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms. Haematologica 2004, 89(12):1492-1497.
19. Krajinovic M., Labuda D., Richer C., Karimi S., Sinnett D. Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 1999, 93(5):1496-1501.
20. Krajinovic M., Lamothe S., Labuda D., Lemieux-Blanchard E., Theoret Y., Moghrabi A., et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004, 103(1):252-257.
21. Lanciotti M., Dufour C., Corral L., Di Michele P., Pigullo S., De Rossi G., et al. Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements. Leukemia 2005, 19(2):214-216.
22. Pakakasama S., Mukda E., Sasanakul W., Kadegasem P., Udomsubpayakul U., Thithapandha A., et al. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia. Am J Hematol 2005, 79(3):202-205.
23. Eickelmann P., Schulz W.A., Rohde D., Schmitz-Drager B., Sies H. Loss of heterozygosity at the NAD(P)H:quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line. Biol Chem Hoppe Seyler 1994, 375(7):439-445.
24. Franco R.F., Morelli V., Lourenco D., Maffei F.H., Tavella M.H., Piccinato C.E., et al. A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease. Br J Haematol 1999, 105(2):556-559.
25. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10(1):111-113.
26. Kaufman Y., Drori S., Cole P.D., Kamen B.A., Sirota J., Ifergan I., et al. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia. Cancer 2004, 100(4):773-782.
27. Hou X., Wang S., Zhou Y., Xu Z., Zou Y., Zhu X., et al. Cyclin D1 gene polymorphism and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population. Int J Hematol 2005, 82(3):206-209.
28. Liu C.Y., Hsu Y.H., Pan P.C., Wu M.T., Ho C.K., Su L., et al. Maternal and offspring genetic variants of AKR1C3 and the risk of childhood leukemia. Carcinogenesis 2008, 29(5):984-990.
29. Eguchi-Ishimae M., Eguchi M., Ishii E., Knight D., Sadakane Y., Isoyama K., et al. The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan. Haematologica 2005, 90(11):1511-1515.
30. Kim N.K., Chong S.Y., Jang M.J., Hong S.H., Kim H.S., Cho E.K., et al. Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia. Anticancer Res 2006, 26(4B):2879-2881.
31. Pakakasama S., Sirirat T., Kanchanachumpol S., Udomsubpayakul U., Mahasirimongkol S., Kitpoka P., et al. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007, 48(1):16-20.
32. Joseph T., Kusumakumary P., Chacko P., Abraham A., Radhakrishna Pillai M. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children. Pediatr Blood Cancer 2004, 43(5):560-567.
33. Reddy H., Jamil K. Polymorphisms in the MTHFR gene and their possible association with susceptibility to childhood acute lymphocytic leukemia in an Indian population. Leuk Lymphoma 2006, 47(7):1333-1339.
34. Smith M.T., McHale C.M., Wiemels J.L., Zhang L., Wiencke J.K., Zheng S., et al. Molecular biomarkers for the study of childhood leukemia. Toxicol Appl Pharmacol 2005, 206(2):237-245.
35. Gaedigk A., Tyndale R.F., Jurima-Romet M., Sellers E.M., Grant D.M., Leeder J.S. NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian. Chinese and Canadian Native Indian and Inuit populations. Pharmacogenetics 1998, 8(4):305-313.
36. Chao C., Zhang Z.F., Berthiller J., Boffetta P., Hashibe M. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15(5):979-987.
37. Kelsey K.T., Ross D., Traver R.D., Christiani D.C., Zuo Z.F., Spitz M.R., et al. Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer 1997, 76(7):852-854.
38. Schulz W.A., Krummeck A., Rosinger I., Eickelmann P., Neuhaus C., Ebert T., et al. Increased frequency of a null-allele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics 1997, 7(3):235-239.
39. Pereira T.V., Rudnicki M., Pereira A.C., Pombo-de-Oliveira M.S., Franco R.F. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15(10):1956-1963.
40. Zintzaras E., Koufakis T., Ziakas P.D., Rodopoulou P., Giannouli S., Voulgarelis M. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. Eur J Epidemiol 2006, 21(7):501-510.
41. van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 1998, 62(5):1044-1051.
42. Dufficy L., Naumovski N., Ng X., Blades B., Yates Z., Travers C., et al. G80A reduced folate carrier SNP influences the absorption and cellular translocation of dietary folate and its association with blood pressure in an elderly population. Life Sci 2006, 79(10):957-966.
43. Chu J., Dolnick B.J. Natural antisense (rTSalpha) RNA induces site-specific cleavage of thymidylate synthase mRNA. Biochim Biophys Acta 2002, 1587(2-3):183-193.
44. Kealey C., Brown K.S., Woodside J.V., Young I., Murray L., Boreham C.A., et al. A common insertion/deletion polymorphism of the thymidylate synthase (TYMS) gene is a determinant of red blood cell folate and homocysteine concentrations. Hum Genet 2005, 116(5):347-353.
45. Cartwright R.A., Gurney K.A., Moorman A.V. Sex ratios and the risks of haematological malignancies. Br J Haematol 2002, 118(4):1071-1077.
46. Pearce M.S., Parker L. Childhood cancer registrations in the developing world: still more boys than girls. Int J Cancer 2001, 91(3):402-406.
47. Mossuz P., Cousin F., Castinel A., Chauvet M., Sotto M.F., Polack B., et al. Effects of two sex steroids (17beta estradiol and testosterone) on proliferation and clonal growth of the human monoblastic leukemia cell line, U937. Leuk Res 1998, 22(11):1063-1072.
48. Dierkes J., Jeckel A., Ambrosch A., Westphal S., Luley C., Boeing H. Factors explaining the difference of total homocysteine between men and women in the European Investigation into Cancer and Nutrition Potsdam study. Metabolism 2001, 50(6):640-645.
49. Morris M.S., Jacques P.F., Selhub J., Rosenberg I.H. Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2000, 152(2):140-148.